一例原发性肾脏高分化神经内分泌肿瘤的18F-FDG PET/CT与68Ga-DOTATATE PET/CT表现
本文报道一例原发性肾脏高分化神经内分泌肿瘤(WDNET,又称肾脏类癌)患者,同时接受了68Ga-DOTATATE PET/CT与18F-FDG PET/CT用于诊断和分期。该病例表明68Ga-DOTATATE PET/CT扫描可能在原发性肾脏WDNET的诊断、分期和随访中发挥作用。原发性肾脏WDNET极为罕见,自1966年首次描述以来文献中约报告100例,但迄今尚无PET/CT显示的病例。
要点
- 原发性肾脏高分化神经内分泌肿瘤极为罕见,自1966年以来文献约报告100例。
- 迄今尚无原发性肾脏WDNET经PET/CT显示的病例报告。
- 本例同时行68Ga-DOTATATE PET/CT与18F-FDG PET/CT用于诊断和分期。
核心结论
- 该病例表明68Ga-DOTATATE PET/CT扫描可能在原发性肾脏WDNET的诊断、分期和随访中发挥作用。
研究设计与样本
- 病例报告:一例原发性肾脏高分化神经内分泌肿瘤患者,接受68Ga-DOTATATE PET/CT与18F-FDG PET/CT检查用于诊断和分期。
主要发现
- 原发性肾脏WDNET自1966年首次描述以来文献中约报告100例,但迄今尚无PET/CT显示的病例。
- 本例患者同时接受了68Ga-DOTATATE PET/CT和18F-FDG PET/CT用于诊断和分期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary renal well-differentiated neuroendocrine tumors (WDNETs), also called renal carcinoids, are extremely rare. Since first described in 1966, approximately 100 cases have been reported in the literature. However, there have been no cases shown by PET/CT to date. We presented a patient with primary renal WDNET who had undergone both 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT for diagnosis and staging. This case illustrated that 68Ga-DOTATATE PET/CT scanning could play a role in the diagnosis, staging, and follow-up of primary renal WDNETs.
引用
- Şahin R, Baykal Koca S, Yücetaş U, et al. 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor. Clin Nucl Med. 2022. PMID: 35384913. doi:10.1097/RLU.0000000000004198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。